secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2026-04-23T23:59:59+00:00
Accession:  0001493152-26-018608
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus Therapeutics appoints Tim Ruan and Dr. Yi Zhang to board; Matthew McMurdo resigns
--------------------------------------------------------------------------------

- Appoints Tim Ruan as Class II director and Audit Committee member; qualifies as audit committee financial expert.
- Appoints Dr. Yi Zhang as Class II director and Nominating Committee member.
- Matthew McMurdo resigned as director on April 22, 2026; resignation not due to any disagreement.
- Annual cash retainer for each new independent director is $30,000, payable quarterly, plus expense reimbursement.
- Both new directors are independent under Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315226018608/0001493152-26-018608-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315226018608/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-018608

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer